Marc Moncrieff

24PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 16, 2026
Implications of wait times for sentinel node biopsy on melanoma disease progression, micrometastatic tumour burden and survival outcomes in the modern treatment era.

|Nov 10, 2025
A Simplified Classification System for In-Transit Melanoma Metastases.

Sofia Breeze, Clare Peterson, Jennifer Garioch

|Aug 29, 2025
Melanoma Great Debate: Targeted Versus Complete Nodal Dissection Following Neoadjuvant Therapy for Melanoma: Is it Time to Push Forward or Hold Off on Continued De-Escalation of Surgery?

Alexander van Akkooi, Charlotte Ariyan, Marc Moncrieff

|Mar 18, 2024
Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective, Randomised Trial.

T S Lee, I Li, B Peric

|Nov 29, 2022
Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients.

Zahra Hussain, Martin J Heaton, Andrew P Snelling

|Jul 18, 2022
Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease.

Marc D Moncrieff, Serigne N Lo, Richard A Scolyer

Pageof 4

Frequent Collaborators

2 joint publications

Jonathan S Zager

2 joint publications

John F Thompson

2 joint publications

Vernon K Sondak

2 joint publications

Ryckie Wade